Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

The search for a cure

Therapeutic vaccine shows potential for HIV control off treatment in early study

News
10 March 2021
New & experimental HIV treatments

HIV capsid inhibitor offers new option for people with highly resistant HIV

News
10 March 2021

CROI 2021: Stati Uniti, ancora marcate le disparità razziali nella lotta all’HIV, Mercoledì 10 marzo 2021

March 2021

CROI 2021: Des disparités raciales marquées persistent aux Etats-Unis dans le domaine du VIH, Mercredi 10 mars 2021

March 2021
Coronavirus

Underlying health conditions play a major role in increased risk of hospitalisation with COVID-19 in people with HIV

News
10 March 2021

CROI 2021: Persistem nos EUA disparidades raciais evidentes em relação ao VIH, Quarta-feira, 10 de março de 2021

March 2021

КРОИ 2021: В США сохраняется выраженная расовая диспропорция в сфере оказания ВИЧ-специализированной помощи, Среда, 10 марта 2021 года

March 2021

CROI 2021: En EE UU se mantienen unas notables discrepancias raciales relacionadas con el VIH, Miércoles, 10 de marzo de 2021

March 2021
Mental & emotional health & wellbeing

Depression, anxiety and loneliness can be improved with mindfulness audio lessons

News
10 March 2021

CROI 2021: Pronounced racial HIV disparities persist in the US, Wednesday 10 March 2021

March 2021
How HIV works

CROI 2021: HIV capsid uncoats in the CD4 nucleus rather than the cytoplasm – viral lifecycle updated…

Editor's pick
i-Base
10 March 2021
Vaginal rings & topical PrEP

90-Day Dapivirine Ring For Women’s HIV Prevention Passes Its First Test In Phase I Study

Editor's pick
Microbicide Trials Network
10 March 2021
Resistance

Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda

News
9 March 2021
Women

Inflammation Could Help Predict HIV Women Cardiovascular Risks

Editor's pick
Contagion Live
9 March 2021
People who inject drugs

As HIV Outbreak Grips West Virginia, Electeds Move to Cripple Syringe Programs

Editor's pick
Filter
9 March 2021
Improving HIV care

Study: Increase in Taking HIV Meds Using Amazon Prime Model

Editor's pick
University of Washington
9 March 2021
Epidemiology

Pronounced racial HIV disparities persist in the US, with some signs of slow improvement

News
9 March 2021
Changing treatment

African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir

News
9 March 2021
Bone & joint problems

Alendronate can prevent bone loss in people starting HIV treatment

News
9 March 2021
Injectable & long-acting PrEP

Reformulated islatravir implant should provide PrEP for over a year

News
9 March 2021
PrEP programmes & uptake

Large numbers now on Descovy PrEP in the United States

News
9 March 2021
Health problems & ageing

By 2030, a quarter of people taking HIV treatment in the US will be over 65 and most will have multiple health concerns

News
8 March 2021
Harm reduction

Inside North America’s first women-only safer injecting facility

Editor's pick
Drug & Alcohol Findings
8 March 2021
PrEP

Sex, PrEP and HIV in trans and non-binary people A research briefing

About HIV
March 2021